Oestradiol measurement during fulvestrant treatment for breast cancer

Biochemical evaluation of menopausal status is used to inform treatment decisions, including clinical trial eligibility in women with oestrogen receptor positive breast cancer. However, fulvestrant may interfere with oestradiol immunoassays and confound accurate assessment in this context. We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Laura J., Monaghan, Phillip J., Armstrong, Anne, Keevil, Brian G., Higham, Claire, Salih, Zena, Howell, Sacha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461991/
https://www.ncbi.nlm.nih.gov/pubmed/30679781
http://dx.doi.org/10.1038/s41416-019-0378-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461991/
https://www.ncbi.nlm.nih.gov/pubmed/30679781
http://dx.doi.org/10.1038/s41416-019-0378-9

Ejemplares similares